Axa’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4M | Buy |
242,916
+397
| +0.2% | +$7.19K | 0.01% | 587 |
|
|
2025
Q1 | $4.96M | Sell |
242,519
-35,747
| -13% | -$732K | 0.02% | 541 |
|
|
2024
Q4 | $7.15M | Sell |
278,266
-66,387
| -19% | -$1.71M | 0.02% | 453 |
|
|
2024
Q3 | $5.72M | Buy |
344,653
+95,261
| +38% | +$1.58M | 0.02% | 511 |
|
|
2024
Q2 | $4.79M | Buy |
249,392
+141
| +0.1% | +$2.71K | 0.01% | 544 |
|
|
2024
Q1 | $5.89M | Sell |
249,251
-27,077
| -10% | -$640K | 0.02% | 518 |
|
|
2023
Q4 | $3.09M | Sell |
276,328
-6,687
| -2% | -$74.7K | 0.01% | 656 |
|
|
2023
Q3 | $2.62M | Buy |
283,015
+58,664
| +26% | +$543K | 0.01% | 665 |
|
|
2023
Q2 | $2.67M | Buy |
+224,351
| New | +$2.67M | 0.01% | 672 |
|